MYT Netherlands Parent B.V.

NYSE:MYTE Stock Report

Market Cap: US$528.6m

MYT Netherlands Parent B.V Valuation

Is MYTE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MYTE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MYTE's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MYTE's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MYTE?

Other financial metrics that can be useful for relative valuation.

MYTE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.6x
Enterprise Value/EBITDA-133.8x
PEG Ration/a

Price to Sales Ratio vs Peers

How does MYTE's PS Ratio compare to its peers?

The above table shows the PS ratio for MYTE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
REAL RealReal
0.7x10.1%US$412.4m
LE Lands' End
0.4x-0.2%US$521.2m
JILL J.Jill
0.6x1.6%US$391.3m
CURV Torrid Holdings
0.4x0.8%US$426.0m
MYTE MYT Netherlands Parent B.V
0.6x9.0%US$528.6m

Price-To-Sales vs Peers: MYTE is expensive based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.5x).

Price to Earnings Ratio vs Industry

How does MYTE's PE Ratio compare vs other companies in the US Specialty Retail Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a9.9%
 n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a9.9%
 n/an/an/a
No more companies

Price-To-Sales vs Industry: MYTE is expensive based on its Price-To-Sales Ratio (0.6x) compared to the US Specialty Retail industry average (0.4x).

Price to Sales Ratio vs Fair Ratio

What is MYTE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MYTE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: MYTE is expensive based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MYTE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$6.14
US$4.75
-22.7%
13.0%US$5.62US$4.03n/a5
Nov ’25US$6.23
US$4.75
-23.8%
13.0%US$5.62US$4.03n/a5
Oct ’25US$3.65
US$4.75
+30.1%
13.0%US$5.62US$4.03n/a5
Sep ’25US$3.73
US$4.95
+32.6%
10.5%US$5.64US$4.02n/a5
Aug ’25US$3.89
US$4.90
+25.9%
10.5%US$5.57US$3.97n/a5
Jul ’25US$5.07
US$4.90
-3.4%
10.5%US$5.57US$3.97n/a5
Jun ’25US$5.37
US$4.91
-8.5%
10.5%US$5.60US$3.99n/a5
May ’25US$4.13
US$3.93
-4.8%
15.8%US$4.91US$2.97n/a5
Apr ’25US$3.52
US$3.94
+12.1%
17.1%US$5.05US$3.02n/a5
Mar ’25US$3.46
US$3.93
+13.5%
18.8%US$5.04US$3.02n/a7
Feb ’25US$2.56
US$3.95
+54.1%
20.2%US$5.09US$2.99n/a7
Jan ’25US$3.19
US$4.30
+34.7%
26.6%US$6.58US$3.01n/a8
Dec ’24US$3.25
US$4.30
+32.4%
27.1%US$6.51US$2.98n/a8
Nov ’24US$2.93
US$5.17
+76.5%
21.0%US$7.82US$3.99US$6.238
Oct ’24US$3.40
US$5.17
+52.1%
21.0%US$7.82US$3.99US$3.658
Sep ’24US$3.73
US$6.28
+68.4%
25.6%US$8.02US$3.40US$3.738
Aug ’24US$4.11
US$6.70
+63.0%
17.7%US$7.99US$4.01US$3.898
Jul ’24US$4.00
US$6.70
+67.5%
17.7%US$7.99US$4.01US$5.078
Jun ’24US$4.08
US$9.38
+129.9%
47.8%US$19.51US$5.95US$5.378
May ’24US$4.87
US$10.11
+107.5%
43.6%US$19.81US$6.05US$4.138
Apr ’24US$7.03
US$13.84
+96.8%
32.4%US$21.29US$7.19US$3.528
Mar ’24US$8.27
US$13.96
+68.8%
25.1%US$20.71US$9.05US$3.469
Feb ’24US$11.44
US$16.32
+42.7%
22.2%US$21.19US$9.03US$2.569
Jan ’24US$8.91
US$16.69
+87.4%
19.3%US$20.90US$10.62US$3.199
Dec ’23US$9.44
US$16.69
+76.8%
18.3%US$20.34US$10.34US$3.258
Nov ’23US$11.72
US$16.55
+41.2%
17.7%US$20.27US$9.99US$2.938

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y